Skip to main content

Emergent files application to expand production of BioThrax – BioPrepWatch

By April 28, 2016News
emergent-biosolution-logo

emergent-biosolution-logo

Emergent BioSolutions has filed a supplemental Biologics License Application with the U.S. Food and Drug Administration to scale up production of its anthrax vaccine BioThrax. BioThrax is the only FDA-approved anthrax vaccine for humans. It’s primarily produced for and purchased by the U.S. military, and has been in distribution since the 1970s.

{iframe}http://bioprepwatch.com/stories/510719372-emergent-files-application-to-expand-production-of-biothrax{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.